Form 4 for TNXP Tonix Pharmaceuticals Holding Corp.
Accepted 2026-06-15 07:00:12 ET · period of report 2026-06-12 · accession 0001493152-26-028608 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 07:00 | 2026-06-12 | TNXP | Taylor Carolyn E. | Dir | P - Purchase | $10.55 | +1,415 | 1,833 | +339% | +$14.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.001 par value | 2026-06-12 | P | A | 1,415 | $10.55 | 1,833 | D | — | — |